Torreya Partners

  • OUR FIRM

  • OUR PEOPLE

  • OUR SERVICES

    • Mergers & Acquisitions
    • Licensing
    • Corporate Finance
    • Strategy & Valuation
    • Restructuring & Bankruptcy

  • TRANSACTIONS

  • CONTACT US



Sale to
January 2008
Midlothian Laboratories, LLC
Sale to Hi-Tech Pharmacal Co.
[Press Release]
Announced: December 2007
Headquarters: Montgomery, AL
President: Bryce Harvey
Senior Vice President of Operations: Denise Wiesemann

Midlothian is a pharmaceutical company that focuses on providing niche generic pharmaceutical products to the U.S. market, focusing on the sales, marketing and distributing of lower cost generic drugs to national pharmaceutical wholesalers, chain drug stores, as well as retail merchandisers. Acting as exclusive financial advisor, Torreya ran a sale process for Midlothian and advised the company on structuring an acquisition by Hi-Tech, a leading manufacturer and marketer of branded and generic liquid pharmaceutical products in the United States. Torreya also acted as exclusive financial advisor in the sale of Midlothian’s parent company, ProEthic, in March 2008.

Copyright © 2010 Torreya Partners LLC. All rights reserved.
Home | Sector Focus | Login
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.